17 results
8-K
EX-10.2
LYEL
Lyell Immunopharma, Inc.
16 Dec 22
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
4:02pm
, without limitation, claims brought pursuant to the California Private Attorneys General Act of 2004, as amended, the California Fair Employment
10-K
s772pte
29 Mar 22
Annual report
4:20pm
424B4
jxsmiddfr fg
18 Jun 21
Prospectus supplement with pricing info
12:00am
S-1/A
n1jbafi
9 Jun 21
IPO registration (amended)
7:12am
S-1
EX-10.12
v8l7zu3rro0
25 May 21
IPO registration
5:28pm
S-1
EX-10.11
yfga b03jnf
25 May 21
IPO registration
5:28pm
S-1
ggbk0 bf5g350
25 May 21
IPO registration
5:28pm
S-1
EX-10.10
rmajtewcbcpc m99w40h
25 May 21
IPO registration
5:28pm
DRS/A
r4xurg 2i3s
12 May 21
Draft registration statement (amended)
12:00am
DRS
EX-10.12
zwgt40
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.11
tce 0adpx
12 Apr 21
Draft registration statement
12:00am
DRS
3t3w 432wa
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.10
sc0 kzycxnc0
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next